All In Biotech

Free tool

FAERS Monitor: Pamelor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018013 or its brand name (Pamelor, Nortriptyline Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,962

Serious

4,261

71% of reports

Hospitalization

1,488

Death reported

757

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective884
  • off label use838
  • pain742
  • headache733
  • fatigue633
  • nausea605
  • hyperhidrosis594
  • hypersensitivity505
  • drug hypersensitivity448
  • constipation441
  • hypertension439
  • rheumatoid arthritis423
  • hepatic enzyme increased422
  • overdose410
  • joint swelling403

Reports by year received

View as table
YearReports
200483
200583
200673
200780
200870
200981
2010196
2011197
2012177
2013121
2014155
2015193
2016262
2017236
2018271
2019408
2020422
2021414
2022418
2023453
2024582
2025543
2026444

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,197 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hepatic enzyme increasedSignal42222.020.08,399
hyperhidrosisSignal59416.315.18,551
rheumatoid arthritisSignal42313.212.04,761
joint swellingSignal40311.810.73,988
hypersensitivitySignal5059.68.83,916
drug hypersensitivitySignal4488.27.52,837
hypertensionSignal4397.36.72,411
constipationSignal4417.16.52,345
overdoseSignal4106.76.12,006
painSignal7424.34.01,905
headacheSignal7334.13.91,786
off label useSignal8383.43.21,460
fatigueSignal6332.92.7798
nauseaSignal6052.72.5670
drug ineffectiveSignal8842.42.2743

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.